Antiphospholipid antibodies and osteonecrosis in systemic lupus erythematosus: a meta-analysis

References

• Matthews AH, Davis DD, Fish MJ, et al. Osteonecrosis (avascular necrosis). statpearls [internet]. Treasure Island (FL). StatPearls Publishing; 2021. PMID: 30725692 Bookshelf ID: NBK537007.(https://pubmed.ncbi.nlm.nih.gov/30725692/).
   Google Scholar
• Hussein S, Suitner M, Béland-Bonenfant S, et al., Monitoring of osteonecrosis in systemic lupus erythematosus: a systematic review and Metaanalysis. J Rheumatol. 45(10): 1462–1476. 2018.
   PubMed Web of Science ®Google Scholar
• Zhang K, Zheng Y, Jia J, et al. Systemic lupus erythematosus patients with high disease activity are associated with accelerated incidence of osteonecrosis: a systematic review and meta-analysis. Clin Rheumatol. 2018;37(1):5–11.
   PubMed Web of Science ®Google Scholar
• Nevskaya T, Gamble MP, Pope JEA meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors Clin Exp Rheumatol. 2017;35(4):700–710.
   PubMed Web of Science ®Google Scholar
• Mezhov V, Segan JD, Tran H, et al. Antiphospholipid syndrome: a clinical review. Med J Aust. 2019;211(4):184–188.
   PubMed Web of Science ®Google Scholar
• Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142.
   Google Scholar
• Sheikh JS, Retzinger GS, Hess EV. Association of osteonecrosis in systemic lupus erythematosus with abnormalities of fibrinolysis. Lupus 1998;7:42–48.
   PubMed Web of Science ®Google Scholar
• Mok MY, Farewell VT, Isenberg DA. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? Ann Rheum Dis. 2000;59:462–467.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Dhillon N, Su J, et al. Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors. Lupus 2017;0:1–6.
   Google Scholar
• Seyedeh TF, Azam SH, Pedram P, et al. Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: a retrospective case-control study. Mod Rheumatol. 2015;25(4):590–594.
   PubMed Web of Science ®Google Scholar
• Calvo-ale´n J, McGwin G, Toloza S, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case–control study. Ann Rheum Dis. 2006;65:785–790.
   PubMed Web of Science ®Google Scholar
• Gladman DAFNAD, Urowitz MURRAYB, Vandanachaudhry-ahluwalia, et al. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol. 2001;28:761–765.
   PubMed Web of Science ®Google Scholar
• Lee J, Kwok S-K, Jung S-M, et al. Osteonecrosis of the hip in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. Lupus. 2014;23:39–45.
   PubMedGoogle Scholar
• Fernandes EGC, Guissa VR, Saviolli C. et al. Osteonecrosis of the jaw on imaging exams of patients with juvenile systemic lupus erythematosus. Br J Rheumatol. 2010;50(1):3–15.
   Google Scholar
• Tse SM, Mok CC. Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus. Lupus 2016;0:1–8.
   Google Scholar
• Prasad R, Ibanez D, Gladman D, et al. The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: a nested case-control study of inception patients. Lupus. 2007;16(3):157–162.
   PubMed Web of Science ®Google Scholar
• Parichat U, Sumapa C, Pongthorn N, et al. Factors associated with osteonecrosis in thai lupus patients a case control study. J Clin Rheumatol. 2009;15:345–349.
   PubMed Web of Science ®Google Scholar
• Yelin Y, Sathish K, Lily SHL, et al. Risk factors for symptomatic avascular necrosis in childhood-onset systemic lupus erythematosus. J Rheumatology. 2015;42:12.
   Web of Science ®Google Scholar
• Jamal AS, Manal ES, Naema S. et al. Predictors of avascular necrosis of the hip in emiratis patients with systemic lupus erythematosus. EGYPTIAN J IMMUNOLOGY. 2010;17(1):29–40.
   PubMedGoogle Scholar
• Sherin MHH, Nermine S, Takwa BY, et al. Risk factors for osteonecrosis severity among Egyptian systemic lupus erythematosus patients: magnetic resonance imaging (MRI) staging. Egyptian Rheumatologist. 2019;41:295–301.
   Web of Science ®Google Scholar
• Laniyati H, Lyndon J, Sandra V. Risk factors for avascular necrosis among Filipino patients with systemic lupus erythematosus. Int J Rheumatic Dis. 2008;11:141–147.
   Web of Science ®Google Scholar
• Nagasawa KOHEI, Ishii YOSHITOMO, Mayumi TAKEHITO, et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheumatic Dis. 1989;48:672–676.
   PubMed Web of Science ®Google Scholar
• Hisada R, Kato M, Ohnishi N, et al. Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosus. Rheumatology 2019;58:645–649.
   PubMed Web of Science ®Google Scholar
• Mont MA, Glueck CJ, Pacheco IH, et al. Risk factors for osteonecrosis in systemic lupus erythematosus. J rheumatology. 1997;24:4.
   Google Scholar
• Migliaresi S, Picillo U, Ambrosone L, et al. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus. 1994;3:37–41.
   PubMed Web of Science ®Google Scholar
• Mok CC, Lau CS, Wong RW. Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol. 1998;37(8):895–900.
   PubMedGoogle Scholar
• Fialho SCMS, Bonfá E, Vitule LF, et al. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus. Lupus. 2007;16:239–244.
   PubMed Web of Science ®Google Scholar
• Mehmet S, Nergis Y, Murat I, et al. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus. Rheumatol Int. 2012;32:177–182.
   PubMed Web of Science ®Google Scholar
• Abu SM, Buskila D, Shoenfeld Y. Osteonecrosis in patients with SLE. Clin Rev Allergy Immunol. 2003;25(1):13–24.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Culliford D, Arden N, et al. What is the risk of having a total hip or knee replacement for patients with lupus? Lupus. 2015;24(2):198–202.
   PubMed Web of Science ®Google Scholar
• Abeles M, Abeles AM, Urman J, et al. Osteonecrosis in SLE. Rheumatol Int. 2012;32(3):833.
   PubMed Web of Science ®Google Scholar
• Lespasio MJ, Sodhi N, Mont MA. Osteonecrosis of the hip: a primer. Perm J. 2019;23:18–100.
   Google Scholar
• Glueck CJ, Freiberg RA, Wang P. Role of thrombosis in osteonecrosis. Curr Hematol Rep. 2003;2(5):417–422.
   PubMedGoogle Scholar
• Masuyama J, Umino T, Murata M, et al. A systemic lupus erythematosus patient with multiple aseptic bone necroses, thrombosis of superior mesenteric artery and anti-phospholipid antibody. Ryumachi. 1992;32(5):502–507.
   PubMedGoogle Scholar
• Zhu KK, Xu WD, Pan HF, et al. The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis. Inflammation. 2014;37:1852–1864.
   PubMed Web of Science ®Google Scholar